| Recruiting | A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Vir NCT07020533 | City of Hope Medical Center | Phase 1 |
| Recruiting | Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia NCT07224100 | University of Washington | Phase 2 |
| Recruiting | Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed NCT06918431 | City of Hope Medical Center | Phase 2 |
| Recruiting | Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemi NCT03932903 | Northwestern University | N/A |
| Recruiting | CAYA Cancer Retrospective Cohort Study NCT07246213 | Resonance, Inc. | — |
| Recruiting | A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukem NCT06514794 | Wugen, Inc. | Phase 2 |
| Recruiting | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma NCT06533748 | St. Jude Children's Research Hospital | Phase 2 |
| Recruiting | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemi NCT06289673 | St. Jude Children's Research Hospital | Phase 4 |
| Recruiting | A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphobla NCT06207123 | University of Chicago | Phase 1 / Phase 2 |
| Recruiting | Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias NCT06364423 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | BeFluBu vs FluBuRux Conditioning in Haploidentical HCT NCT06477549 | St. Petersburg State Pavlov Medical University | Phase 2 |
| Recruiting | Vitamin A and D Supplementation in Allogeneic HCT NCT06508099 | St. Petersburg State Pavlov Medical University | Phase 2 |
| Completed | A Study of PD5K3 in Healthy Adult Volunteers NCT06527781 | Chongqing Peg-Bio Biopharm Co., Ltd. | Phase 1 |
| Recruiting | Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma NCT05602194 | Children's Oncology Group | Phase 3 |
| Active Not Recruiting | A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leuke NCT05885464 | Beam Therapeutics Inc. | Phase 1 / Phase 2 |
| Recruiting | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Recruiting | MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing NCT05794880 | Medical College of Wisconsin | N/A |
| Active Not Recruiting | A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer NCT05428176 | City of Hope Medical Center | N/A |
| Recruiting | Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies NCT05476770 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 1 |
| Completed | A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refrac NCT04984356 | Wugen, Inc. | Phase 1 |
| Recruiting | Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hemat NCT04195633 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation NCT04942730 | St. Petersburg State Pavlov Medical University | Phase 2 |
| Completed | SARS-CoV-2 Donor-Recipient Immunity Transfer NCT04666025 | City of Hope Medical Center | — |
| Active Not Recruiting | Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation NCT04060277 | City of Hope Medical Center | Phase 2 |
| Recruiting | Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Bloo NCT03779854 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia ( NCT03792256 | Children's Oncology Group | Phase 1 |
| Recruiting | CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT NCT03810196 | Children's Hospital of Philadelphia | N/A |
| Completed | Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma NCT03328104 | Emory University | Phase 1 |
| Unknown | Study of Prognostic Factors in Adult Lymphoblastic Lymphoma NCT03571997 | PETHEMA Foundation | — |
| Recruiting | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders NCT03314974 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Active Not Recruiting | High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children Wit NCT03178617 | City of Hope Medical Center | N/A |
| Completed | A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acu NCT03181126 | AbbVie | Phase 1 |
| Completed | Allo HSCT Using RIC for Hematological Diseases NCT02661035 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Completed | Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute NCT03023046 | University of Washington | Phase 2 |
| Completed | Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT02960646 | M.D. Anderson Cancer Center | Phase 1 |
| Recruiting | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases NCT01962636 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Thiopurine EnhAnced Maintenance Therapy NCT02912676 | Kjeld Schmiegelow | Phase 1 / Phase 2 |
| Unknown | ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors NCT02938741 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Completed | Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic L NCT02881086 | Goethe University | Phase 3 |
| Unknown | Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL NCT03564704 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Active Not Recruiting | LBL-2016 for Children or Adolescents in China NCT02845882 | Children's Cancer Group, China | Phase 3 |
| Terminated | Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia NCT02419469 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV a NCT02506933 | City of Hope Medical Center | Phase 2 |
| Completed | A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leuk NCT01614197 | Therapeutic Advances in Childhood Leukemia Consortium | Phase 1 |
| Terminated | Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults NCT02535806 | Children's Mercy Hospital Kansas City | Phase 2 |
| Completed | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Rela NCT02220985 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Old NCT02228772 | Massachusetts General Hospital | Phase 1 |
| Terminated | A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in NCT02257684 | Jazz Pharmaceuticals | Phase 2 |
| Recruiting | Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Canc NCT01790152 | Children's Oncology Group | — |
| Withdrawn | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies NCT01163201 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Terminated | L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL NCT01910428 | ERYtech Pharma | Phase 1 |
| Completed | Safety Study of CPX-351 in Children With Relapsed Leukemia or Lymphoma NCT01943682 | Children's Hospital Medical Center, Cincinnati | Phase 1 |
| Unknown | ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell NCT02290132 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Completed | Mitoxantrone and Clofarabine for Treatment of Recurrent NHL or Acute Leukemia NCT01842672 | New York Medical College | Phase 1 / Phase 2 |
| Terminated | Acute Lymphoblastic Leukemia Registry at Asan Medical Center NCT01761682 | Asan Medical Center | — |
| Completed | A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therap NCT01643408 | Jazz Pharmaceuticals | Phase 2 |
| Active Not Recruiting | SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma NCT01574274 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma NCT01451515 | St. Jude Children's Research Hospital | Phase 2 |
| Unknown | Osteonecroses in Pediatric Patients With ALL NCT01619124 | Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immu | — |
| Completed | Safety and Tolerability of HSC835 in Patients With Hematological Malignancies NCT01474681 | Novartis Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | Hyper-CVAD Treatment in Lymphoblastic Lymphoma NCT01813344 | Ajou University School of Medicine | — |
| Unknown | Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia NCT01513603 | New York Medical College | Phase 2 |
| Completed | Combination Chemotherapy and Ofatumumab in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblasti NCT01363128 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy NCT01184885 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | EARLY_Phase 1 |
| Terminated | Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors NCT01100658 | University of Minnesota | N/A |
| Active Not Recruiting | Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders NCT01177527 | Dana-Farber Cancer Institute | — |
| Completed | Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patient NCT00949741 | Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie | — |
| Unknown | Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensi NCT00882011 | Fondazione Italiana Linfomi - ETS | — |
| Completed | Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia NCT00866749 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients NCT00412243 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patient NCT00719888 | Fred Hutchinson Cancer Center | Phase 2 |
| Unknown | Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma NCT00195871 | Centre Henri Becquerel | Phase 2 |
| Completed | Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults NCT00199082 | Nicola Goekbuget | Phase 4 |
| Completed | Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablat NCT00587054 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma NCT00187122 | St. Jude Children's Research Hospital | N/A |
| No Longer Available | Expanded Access to Navitoclax NCT03592576 | AbbVie | — |
| Approved For Marketing | JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli NCT04943952 | Jazz Pharmaceuticals | — |